IRT Living (IRT)

NYSEReal EstateReit - ResidentialSnapshot 2026-10-23

$14.96-1.38%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge IRT Living’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	172.41M
EPS	—	0.089
Annual ending 2026-12-31
Revenue	—	676.39M
EPS	—	0.147
Annual ending 2027-12-31
Revenue	—	810.82M
EPS	—	0.196

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Stabilize or improve cash from operating activities near $55M+	A primary condition in IRT Living's published investment case. The stated target is >= $55 million.	Intact	cash from operations falls below $55 million	Cash from operations: $80.916M FY2026-Q2; GAAP. Published target: >= $55 million. Target period is not explicitly aligned with this observation. Source published Aug 4, 202680,916,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 5 of last 5 quarters. Cash from operating activities showed variability, from $82.2 million in 2025-Q2 down to $55.3 million in 2026-Q1, then rising to $80.9 million in 2026-Q2. Management maintains focus on strong cash flow, with recent quarters showing recovery and strength. Delivery assessment Oct 24, 2026
Maintain dividend per share at $0.17	The company keeps its dividend steady at $0.17 per share.	Intact	dividend per share falls below $0.17	Dividend per share: $0.18 per share FY2026-Q2; GAAP. Published target: $0.17 per share. Target period is not explicitly aligned with this observation. Source published Aug 4, 20260.18 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b4d21a5d-7324-4ecd-841a-ad20533bd4f9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 3 quarters. Dividend per share increased from $0.17 in 2026-Q1 to $0.18 in 2026-Q2, reflecting a 5.9% increase. Management has consistently declared and increased dividends, delivering on this priority. Delivery assessment Oct 24, 2026
Maintain EPS guidance range $0.21 to $0.28 for 2026	A primary condition in IRT Living's published investment case. The stated target is EPS between $0.21 and $0.28.	Intact	EPS guidance falls below $0.21 for FY26	Diluted EPS: $0.01 per share FY2026-Q2; GAAP. Published target: EPS between $0.21 and $0.28. Target period is not explicitly aligned with this observation. Source published Aug 4, 20260.01 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b4d21a5d-7324-4ecd-841a-ad20533bd4f9. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenueUnavailable

$0.69B → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$692,888,560	2 / 7
2026-07-25	Unavailable	$692,888,560	2 / 7
2026-07-26	Unavailable	$692,888,560	2 / 7
2026-07-27	Unavailable	$693,702,703	2 / 5
2026-07-28	Unavailable	$692,888,560	2 / 7
2026-07-29	Unavailable	$692,888,560	2 / 7
2026-07-30	Unavailable	$692,888,560	2 / 7
2026-07-31	Unavailable	$692,888,560	2 / 7
2026-08-01	Unavailable	$693,702,703	2 / 5
2026-08-02	Unavailable	$692,888,560	2 / 7
2026-08-03	Unavailable	$692,888,560	2 / 7
2026-08-04	Unavailable	$692,888,560	2 / 7
2026-08-05	Unavailable	$692,888,560	2 / 7
2026-08-06	Unavailable	$695,418,700	2 / 7
2026-08-07	Unavailable	$698,384,241	2 / 5
2026-08-08	Unavailable	$698,384,241	2 / 5
2026-08-09	Unavailable	$696,775,770	2 / 9
2026-08-10	Unavailable	$698,384,241	2 / 5
2026-08-12	Unavailable	$697,647,240	2 / 8
2026-08-13	Unavailable	$698,384,241	2 / 5
2026-08-14	Unavailable	$698,384,241	2 / 5
2026-08-15	Unavailable	$698,384,241	2 / 6
2026-08-16	Unavailable	$698,384,241	2 / 6
2026-08-17	Unavailable	$698,384,241	2 / 6
2026-08-18	Unavailable	$698,384,241	2 / 6
2026-08-19	Unavailable	$698,384,241	2 / 6
2026-08-20	Unavailable	$698,384,241	3 / 5
2026-08-21	Unavailable	$698,384,241	3 / 6
2026-08-22	Unavailable	$698,384,241	3 / 6
2026-08-23	Unavailable	$698,384,241	3 / 6
2026-08-24	Unavailable	$698,384,241	3 / 6
2026-08-25	Unavailable	$698,384,241	3 / 6
2026-08-26	Unavailable	$698,384,241	3 / 6
2026-08-27	Unavailable	$698,384,241	3 / 6
2026-08-28	Unavailable	$698,384,241	3 / 6
2026-08-29	Unavailable	$698,384,241	3 / 6
2026-08-30	Unavailable	$698,384,241	3 / 6
2026-08-31	Unavailable	$698,384,241	3 / 6
2026-09-01	Unavailable	$698,384,241	3 / 6
2026-09-02	Unavailable	$698,384,241	3 / 6
2026-09-03	Unavailable	$698,124,992	3 / 6
2026-09-04	Unavailable	$698,124,992	3 / 6
2026-09-05	Unavailable	$697,867,240	3 / 6
2026-09-06	Unavailable	$697,867,240	3 / 6
2026-09-07	Unavailable	$697,867,240	3 / 6
2026-09-08	Unavailable	$697,867,240	3 / 6
2026-09-09	Unavailable	$697,867,240	3 / 6
2026-09-10	Unavailable	$697,867,240	3 / 6
2026-09-11	Unavailable	$795,979,654	3 / 5
2026-09-12	Unavailable	Unavailable	3 / 3
2026-09-13	Unavailable	Unavailable	3 / 3
2026-09-14	Unavailable	Unavailable	2 / 2
2026-09-15	Unavailable	Unavailable	2 / 2
2026-09-16	Unavailable	Unavailable	2 / 2
2026-09-17	Unavailable	Unavailable	2 / 2
2026-09-18	Unavailable	Unavailable	2 / 2
2026-09-19	Unavailable	Unavailable	2 / 2
2026-09-20	Unavailable	Unavailable	2 / 2
2026-09-21	Unavailable	Unavailable	2 / 2
2026-09-22	Unavailable	Unavailable	2 / 2
2026-09-23	Unavailable	Unavailable	2 / 2
2026-09-24	Unavailable	Unavailable	2 / 2
2026-09-25	Unavailable	Unavailable	2 / 2
2026-09-26	Unavailable	Unavailable	2 / 2
2026-09-27	Unavailable	Unavailable	2 / 2
2026-09-28	Unavailable	Unavailable	2 / 2
2026-09-29	Unavailable	Unavailable	2 / 2
2026-09-30	Unavailable	Unavailable	2 / 2
2026-10-01	Unavailable	Unavailable	2 / 2
2026-10-02	Unavailable	Unavailable	2 / 2
2026-10-03	Unavailable	Unavailable	2 / 2
2026-10-04	Unavailable	Unavailable	2 / 2
2026-10-05	Unavailable	Unavailable	2 / 2
2026-10-06	Unavailable	Unavailable	2 / 2
2026-10-07	Unavailable	Unavailable	2 / 2
2026-10-08	Unavailable	Unavailable	2 / 2
2026-10-09	Unavailable	Unavailable	2 / 2
2026-10-10	Unavailable	Unavailable	2 / 2
2026-10-11	Unavailable	Unavailable	2 / 3
2026-10-12	Unavailable	Unavailable	2 / 3
2026-10-13	Unavailable	Unavailable	2 / 3
2026-10-14	Unavailable	Unavailable	2 / 3
2026-10-15	Unavailable	Unavailable	1 / 3
2026-10-16	Unavailable	Unavailable	1 / 3
2026-10-17	Unavailable	Unavailable	1 / 3
2026-10-18	Unavailable	Unavailable	1 / 3
2026-10-19	Unavailable	Unavailable	1 / 3
2026-10-20	Unavailable	Unavailable	1 / 3
2026-10-21	Unavailable	Unavailable	1 / 3
2026-10-22	Unavailable	Unavailable	1 / 3
2026-10-23	Unavailable	Unavailable	1 / 3
2026-10-24	Unavailable	Unavailable	1 / 3

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	10	4
2026-06-01	10	4
2026-07-01	11	4
2026-08-01	11	3
2026-09-01	11	3
2026-10-01	10	3

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 10 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades3 maintains

Recent actions · Sep 25–Oct 24 · 3 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

UBSOct 14 · prior Sep 15

$18.00 → $17.00-5.6%

$0$9.90$19.80

0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Stabilize or improve cash from operating activities near $55M+Cash from operations: $80.916M
Maintain dividend per share at $0.17Dividend per share: $0.18 per share
Maintain EPS guidance range $0.21 to $0.28 for 2026Diluted EPS: $0.01 per share

Next proof point

Nov 2, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-17.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

IRT Living outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

IRT is a rate-sensitive real estate business with a renovation-led growth program, rather than a clear durable compounder or turnaround. The thesis is currently intact, though the signal has shifted from mildly favorable to mixed and company momentum has fallen sharply.

What's priced into IRT Living

The valuation evidence is mixed: IRT is described as cheap versus peers, yet its overall priced-in tag is stretched, with an expectations gap of 0.19 and low model confidence. Fragility is rated low, but the evidence does not clearly show how much future growth the market already assumes.

What the fundamentals likely do

Near term, the company has reaffirmed its 2026 guidance, increased renovation volume and returns, and raised its dividend per share. However, earnings quality is marked loss-making, recent performance is neutral, and the risk snapshot notes a history of recent misses despite a low stated miss probability.

What IRT Living hinges on

Over the next few quarters, maintaining guidance and continuing to improve renovation volume and returns are key execution tests. Rate cuts or continued strength from real estate peers could support the sector backdrop, while a guidance reduction would be a meaningful negative.